Literature DB >> 16185938

Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.

Timo Kahles1, Christian Foerch, Matthias Sitzer, Michael Schroeter, Helmuth Steinmetz, Abdelhaq Rami, Tobias Neumann-Haefelin.   

Abstract

Thrombolysis with tPA for acute ischemic stroke is associated with an increased risk of intracerebral hemorrhage. We investigated the impact of thrombolysis with tPA on the blood-brain barrier in a suture occlusion model in rats. Cerebral ischemia was performed for 2 h followed by 22 h of reperfusion. Treatment groups received either saline (A), 10 mg/kg bw rtPA (B) or "activated" rtPA (ArtPA, C, rtPA with in vitro clot contact). Blood-brain-barrier damage assessed by Evans blue extravasation as a permeability marker was significantly enhanced in basal ganglia of group C compared to groups A or B. Likewise was the upregulation of MMP-9. Interestingly, results of the rtPA and saline group showed only minor and not statistically significant differences. The results of the present study indicate a major role for thrombus-thrombolytic interaction in focal cerebral ischemia with subsequent increased BBB permeability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185938     DOI: 10.1016/j.vph.2005.07.008

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  17 in total

1.  Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.

Authors:  Li Sun; Wei Zhou; Christian Mueller; Clemens Sommer; Sabine Heiland; Alexander T Bauer; Hugo H Marti; Roland Veltkamp
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

Review 2.  Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

Authors:  J Marc Simard; Zhihua Geng; Frank L Silver; Kevin N Sheth; W Taylor Kimberly; Barney J Stern; Mario Colucci; Volodymyr Gerzanich
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

3.  Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.

Authors:  Ran Liu; Qing Liu; Shaoqing He; James W Simpkins; Shao-Hua Yang
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

4.  Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Authors:  Sophie Gautier; Thavarak Ouk; Olivier Petrault; Jacques Caron; Régis Bordet
Journal:  Br J Pharmacol       Date:  2009-02-04       Impact factor: 8.739

5.  Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.

Authors:  Hongqi Xin; Yi Li; Li Hong Shen; Xianshuang Liu; Xinli Wang; Jing Zhang; Siamak Pourabdollah-Nejad D; Chunling Zhang; Li Zhang; Hao Jiang; Zheng Gang Zhang; Michael Chopp
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

6.  Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis.

Authors:  Norbert Nighoghossian; Fatima Abbas; Tae-Hee Cho; Ana Filipa Geraldo; Vincent Cottaz; Elie Janecek; Laura Mechtouff; Magali Bischoff; Carlos El Khoury; Anne Marie Schott; Laurent Derex; Marc Hermier; Louis Guy Tisserand; Roxana Amelie; Leila Chamard; Yves Berthezene
Journal:  Neuroradiology       Date:  2016-07-22       Impact factor: 2.804

7.  Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

Authors:  Livia S Machado; Irina Y Sazonova; Anna Kozak; Daniel C Wiley; Azza B El-Remessy; Adviye Ergul; David C Hess; Jennifer L Waller; Susan C Fagan
Journal:  Stroke       Date:  2009-07-23       Impact factor: 7.914

8.  Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.

Authors:  Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

9.  Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.

Authors:  Yoji Tanaka; Hideto Ishii; Megumi Hiraoka; Naoyuki Miyasaka; Toshihiko Kuroiwa; Katherine A Hajjar; Tsukasa Nagaoka; Timothy Q Duong; Kikuo Ohno; Masayuki Yoshida
Journal:  Brain Res       Date:  2007-07-06       Impact factor: 3.252

10.  Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice.

Authors:  Sébastien Lenglet; Fabrizio Montecucco; Adam Denes; Graham Coutts; Emmanuel Pinteaux; François Mach; Karl Schaller; Yvan Gasche; Jean-Christophe Copin
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.